Table 2.
Trial | Regimen (treatment group) | DFS at three years (%) | DFS at five years (%) |
---|---|---|---|
MOSAIC [1, 2••] | FOLFOX4 (experimental) | 72.2 | 66.4 |
NSABP C-07 [3, 4•] | FLOX (experimental) | NE | 64.4 |
NO16968 [5••, 6] | XELOX (experimental) | 70.9 | 66.1 |
NSABP C-08 [13•] | mFOLFOX6 (control) | 72 | NE |
AVANT [17] | FOLFOX4 (control) | 76 | NE |
NCCTG [16] | mFOLFOX6 (control) | 75 | NE |
PETACC8 Intergroup [18] | FOLFOX4 (control) | 78 | NE |
NE, not evaluated